First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Ardent Health: the story is balanced — Same-facility admission growth and case mix index (higher acuity = higher reimbursement): 1% volume growth typically…
★ Analysts see FY2027 revenue reaching $6.8B — +4.6% growth in a single year.
What Moves the Stock
1Same-facility admission growth and case mix index (higher acuity = higher reimbursement): 1% volume growth typically adds $60M revenue
2Labor cost per adjusted admission: contract labor as % of total labor (target <5%, industry average 8-10% in 2024-2025)
3Payer mix shift: 1% shift from Medicaid to commercial insurance adds approximately 200-300bps to operating margin
4Medicare/Medicaid reimbursement rate updates: annual CMS IPPS updates (typically 2-3%) and state Medicaid rate changes
5Uncompensated care levels: bad debt and charity care as % of revenue (currently estimated 8-10% of gross charges)
6Inpatient services (estimated 50-55% of revenue): medical/surgical admissions, ICU care, maternity services with revenue per admission averaging $12,000-15,000
7Outpatient services (estimated 35-40%): ambulatory surgery centers, imaging, lab services, emergency department visits not requiring admission
value - The 0.2x P/S, 1.1x P/B, and 5.6x EV/EBITDA multiples indicate deep value territory…
Rising rates increase interest expense on the company's $2.5B+ debt load (implied from 1.84x D/E and equity base)…
Watch on earnings: Monthly admission trends by service line (medical/surgical, ICU, maternity, behavioral health) and emergency department visit volumes, Payer mix percentages: commercial vs. Medicare vs. Medicaid vs. uninsured - track quarterly for margin impact, Labor cost per adjusted admission and contract labor as % of total labor expense - key margin driver.
One Sentence Summary:
Ardent Health: the story is balanced — same-facility admission growth and case mix index (higher acuity = higher reimbursement): 1% volume growth typically adds $60m revenue.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.